首页> 外文期刊>Biosensors & Bioelectronics: The International Journal for the Professional Involved with Research, Technology and Applications of Biosensers and Related Devices >A quantum dot-aptamer beacon using a DNA intercalating dye as the FRET reporter: Application to label-free thrombin detection
【24h】

A quantum dot-aptamer beacon using a DNA intercalating dye as the FRET reporter: Application to label-free thrombin detection

机译:使用DNA嵌入染料作为FRET报告基因的量子点适体信标:在无标记凝血酶检测中的应用

获取原文
获取原文并翻译 | 示例
           

摘要

A new quantum dot (QD)-aptamer (apt) beacon that acts by folding-induced dissociation of a DNA intercalating dye, BOBO-3(B), is demonstrated with label-free thrombin detection. The beacon, denoted as QD-apt:B, is constructed by (1) coupling of a single-stranded thrombin aptamer to Qdot 565 via EDC/Sulfo-NHS chemistry and (2) staining the duplex regions of the aptamer on QD with excess BOBO-3 before thrombin binding. When mixing a thrombin sample with QD-apt:B, BOBO-3 is competed away from the beacon due to target-induced aptamer folding, which then causes a decrease in QD fluorescence resonance energy transfer (FRET)-mediated BOBO-3 emission and achieves thrombin quantitation. In this work, the effects of Mg~(2+), coupling time, and aptamer type on the beacon's performances are investigated and discussed thoroughly with various methods, including transmission electron microscopy (TEM), dynamic light scattering (DLS), and two-color differential gel electrophoresis. Using the best aptamer beacon (HTQ37), we attain highly specific and wide-range detection (from nM to μM) of thrombin in buffer, and the beacon can sense nM-range thrombin in 15% diluted serum. Compared to the reported QD aptamer assays, our method is advantageous from the aspect of using a simple sensory unit design without losing the detection sensitivity. Therefore, we consider the QD-apt:B beacon a potential alternative to immuno-reagents and an effective tool to study nucleic acid folding on QD as well.
机译:无标记的凝血酶检测证明了一种新的量子点(QD)-适体(apt)信标,其通过折叠诱导的DNA嵌入染料BOBO-3(B)的解离起作用。通过(1)通过EDC / Sulfo-NHS化学将单链凝血酶适体与Qdot 565偶联,以及(2)用过量的QD对适体的双链体区域进行染色,来构建表示为QD-apt:B的信标。凝血酶结合前的BOBO-3。当将凝血酶样品与QD-apt:B混合时,BOBO-3由于靶标诱导的适体折叠而与信标竞争,从而导致QD荧光共振能量转移(FRET)介导的BOBO-3发射减少和实现凝血酶定量。在这项工作中,用透射电子显微镜(TEM),动态光散射(DLS)和两种方法研究了Mg〜(2+),耦合时间和适体类型对信标性能的影响,并进行了深入讨论。色差动凝胶电泳。使用最佳适体信标(HTQ37),我们可以在缓冲液中对凝血酶进行高度特异性和宽范围的检测(从nM到μM),并且该信标可以在15%稀释的血清中检测nM范围的凝血酶。与已报道的QD适体测定相比,从使用简单的感官单元设计的角度来看,我们的方法具有优势,而不会降低检测灵敏度。因此,我们认为QD-apt:B信标是免疫试剂的潜在替代品,也是研究QD上核酸折叠的有效工具。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号